PNC-27 is a 27-amino acid peptide containing a p53 MDM-2 binding domain fused to a membrane-penetrating sequence, designed to selectively induce apoptosis in cancer cells that aberrantly express HDM-2 (MDM-2) on their plasma membrane.
Anticancer Peptide
PNC-27 is a 27-amino acid peptide containing a p53 MDM-2 binding domain fused to a membrane-penetrating sequence, designed to selectively induce apoptosis in cancer cells that aberrantly express HDM-2 (MDM-2) on their plasma membrane.
Week-by-week dosing, reconstitution steps, supplies checklist, and cycle tips.
Week-by-week dosing protocolNo clinics in our directory yet. Browse all clinics.
Find a Peptide Clinic Near YouArticles about PNC-27 and related topics
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.